MMP9 and carotid atherosclerosis: The rs3918242 polymorphism in the MMP‐9 promoter may reduce the rate of transcription by inhibiting protein binding, which downregulates MMP‐9 expression, and is associated with carotid atherosclerosis and increased IS risk (Lin et al., 2012).